Top compounds associated with response to NUDT15


Feature Type Standardized
Nominal ANOVA
mRNA lapatinib CCLE pan-cancer AAC -0.00014 1
mRNA GW 441756 GDSC1000 pan-cancer AAC -8.2e-05 1
mRNA necrostatin-7 CTRPv2 pan-cancer AAC -7.9e-05 1
mRNA serdemetan FIMM pan-cancer AAC 0.00024 1
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -1.5e-05 1
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 4.2e-06 1
Download CSV